Company intelligence / Profile preview
Saint Petersburg Scientific Research Institute of Vaccines and Serums
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
Overview
SPbSRIVS FMBA of Russia is a leading Russian vaccine manufacturer with GMP certification, best known for its seasonal influenza vaccines (FLU-M® and Flu-М Tetra) with large-scale manufacturing and export capacity; it also developed Convacell®, a recombinant protein COVID-19 vaccine targeting the N-protein, with evidence of safety, immunogenicity, and protective efficacy in preclinical and early clinical trials[2][6][7][8].
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant protein
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Saint Petersburg Scientific Research Institute of Vaccines and Serums.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Saint Petersburg Scientific Research Institute of Vaccines and Serums.